Pharmacological study of piroheptine, a new antiparkinson drug, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-ethyl-2-methylpyrrolidine. I. Effects on drug-induced tremor and catatonia, and on adrenergic actions.

Source:http://linkedlifedata.com/resource/pubmed/id/4626187

Download in:

View as

General Info

PMID
4626187